https://www.selleckchem.com/pr....oducts/3-deazaadenos
ials.BACKGROUND To meet clinical needs, fluorescence-guided surgery has emerged as a new technique that guides surgeons in the resection of cancerous tissue by highlighting tumour lesions during surgery. We aimed to evaluate the novel ovarian cancer-specific antibody fluorescent probe COC183B2-800 (COC183B2 conjugated with IRDye800CW) in tumour-specific imaging to determine if it can help surgeons remove malignant lesions under fluorescence guidance. METHODS The expression of OC183B2 antigen in epithelial ovarian
Beğen
Yorum Yap
Paylaş
